Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K H Plate

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Cancer Research|April 1, 1996
Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivoB Millauer, M P Longhi, K H Plate, et al.
Neuropathology and Applied Neurobiology|April 24, 1999
Differential downregulation of vascular endothelial growth factor by dexamethasone in normoxic and hypoxic rat glioma cellsM R Machein, J Kullmer, V Rönicke, et al.
Brain : a Journal of Neurology|November 14, 2007
Serum GFAP is a diagnostic marker for glioblastoma multiformeC S Jung, C Foerch, A Schänzer, et al.
Annals of Hematology|March 4, 2003
Regulators of angiogenesis as targets for anti-angiogenic tumor therapyG Breier, R Heidenreich, A Gaumann, et al.
Human Genetics|September 1, 1996
Mutations in the VHL tumor suppressor gene and associated lesions in families with von Hippel-Lindau disease from central EuropeD Glavac, H P Neumann, C Wittke, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|April 18, 2001
Activation of c-Jun NH2-terminal kinase/stress-activated protein kinase (JNK/SAPK) is critical for hypoxia-induced apoptosis of human malignant melanomaM Kunz, S Ibrahim, D Koczan, et al.
Neuropathology and Applied Neurobiology|October 15, 2013
Loss of FUBP1 expression in gliomas predicts FUBP1 mutation and is associated with oligodendroglial differentiation, IDH1 mutation and 1p/19q loss of heterozygosityP Baumgarten, P N Harter, M Tönjes, et al.
British Journal of Cancer|March 19, 2025
CAR-NK cell therapy combined with checkpoint inhibition induces an NKT cell response in glioblastomaF Strassheimer, P Elleringmann, G Ludmirski, et al.
Acta Neuropathologica Communications|March 2, 2018
CD74 regulates complexity of tumor cell HLA class II peptidome in brain metastasis and is a positive prognostic marker for patient survivalP S Zeiner, J Zinke, D J Kowalewski, et al.
Nature Medicine|May 1, 2001
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditionsP Carmeliet, L Moons, A Luttun, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Cancer Research|April 1, 1996
Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivoB Millauer, M P Longhi, K H Plate, et al.
Neuropathology and Applied Neurobiology|April 24, 1999
Differential downregulation of vascular endothelial growth factor by dexamethasone in normoxic and hypoxic rat glioma cellsM R Machein, J Kullmer, V Rönicke, et al.
Brain : a Journal of Neurology|November 14, 2007
Serum GFAP is a diagnostic marker for glioblastoma multiformeC S Jung, C Foerch, A Schänzer, et al.
Annals of Hematology|March 4, 2003
Regulators of angiogenesis as targets for anti-angiogenic tumor therapyG Breier, R Heidenreich, A Gaumann, et al.
Human Genetics|September 1, 1996
Mutations in the VHL tumor suppressor gene and associated lesions in families with von Hippel-Lindau disease from central EuropeD Glavac, H P Neumann, C Wittke, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|April 18, 2001
Activation of c-Jun NH2-terminal kinase/stress-activated protein kinase (JNK/SAPK) is critical for hypoxia-induced apoptosis of human malignant melanomaM Kunz, S Ibrahim, D Koczan, et al.
Neuropathology and Applied Neurobiology|October 15, 2013
Loss of FUBP1 expression in gliomas predicts FUBP1 mutation and is associated with oligodendroglial differentiation, IDH1 mutation and 1p/19q loss of heterozygosityP Baumgarten, P N Harter, M Tönjes, et al.
British Journal of Cancer|March 19, 2025
CAR-NK cell therapy combined with checkpoint inhibition induces an NKT cell response in glioblastomaF Strassheimer, P Elleringmann, G Ludmirski, et al.
Acta Neuropathologica Communications|March 2, 2018
CD74 regulates complexity of tumor cell HLA class II peptidome in brain metastasis and is a positive prognostic marker for patient survivalP S Zeiner, J Zinke, D J Kowalewski, et al.
Nature Medicine|May 1, 2001
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditionsP Carmeliet, L Moons, A Luttun, et al.
Pageof 8